Pesquisar
AC Immune SA
ACIUAdicionar à lista de desejos
2.660USD
-0.170-6.01%
Fechamento 09-24 16:00（ET）
270.71MValor de mercado
PerdaP/L TTM
Sobre o AC Immune SA Empresa
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
AC Immune SA Perfil
Código da empresaACIU
Nome da EmpresaAC Immune SA
Data de listagemSep 23, 2016
CEOPfeifer (Andrea)
Número de funcionários133
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 23
EndereçoEPFL Innovation Park
CidadeLAUSANNE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postal1015
Telefone41213459121
Sitehttps://www.acimmune.com/
Código da empresaACIU
Data de listagemSep 23, 2016
CEOPfeifer (Andrea)
Executivos da empresa AC Immune SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Prof. Carl June, M.D.
Prof. Carl June, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
75.27K
+22.01%
Mr. Piergiorgio Donati
Mr. Piergiorgio Donati
Chief Technical Operations Officer
Chief Technical Operations Officer
74.24K
+38.31%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Prof. Dr. Andrea Pfeifer, Ph.D.
Prof. Dr. Andrea Pfeifer, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
3.41M
-0.29%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Mr. Christopher Roberts
Mr. Christopher Roberts
Chief Financial Officer
Chief Financial Officer
75.37K
+49.52%
Perguntas frequentes
Quem são os cinco principais acionistas de AC Immune SA?
Os cinco principais acionistas de AC Immune SA são: Prof. Dr. Andrea Pfeifer, Ph.D.
Quantas instituições possuem ações da AC Immune SA (ACIU)?
Em 2026Q1, 106 instituições possuíam ações da AC Immune SA, com valor de mercado aproximado de 26.78M, representando 26.32% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1698579.00.